{"id":50616,"date":"2025-12-13T22:22:42","date_gmt":"2025-12-13T14:22:42","guid":{"rendered":"https:\/\/flcube.com\/?p=50616"},"modified":"2025-12-13T22:22:43","modified_gmt":"2025-12-13T14:22:43","slug":"lilly-to-invest-over-6-billion-in-alabama-glp-1-manufacturing-hub-for-orforglipron","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=50616","title":{"rendered":"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron"},"content":{"rendered":"\n<p><strong>Eli Lilly &amp; Co.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/LLY:NYSE\">NYSE: LLY<\/a>) announced plans to invest <strong>more than USD\u202f6\u202fbillion<\/strong> in a new manufacturing facility in Huntsville, Alabama. The next\u2011generation active pharmaceutical ingredient (API) plant will produce <strong>small molecule synthetic and peptide medicines<\/strong>, including <strong>orforglipron<\/strong>, Lilly\u2019s first oral small\u2011molecule <strong>GLP\u20111 receptor agonist<\/strong> targeted for obesity.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-investment-amp-facility-overview\">Investment &amp; Facility Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Total Investment<\/strong><\/td><td>&gt;\u202fUSD\u202f6\u202fbillion<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Huntsville, Alabama<\/td><\/tr><tr><td><strong>Facility Type<\/strong><\/td><td>Next\u2011gen synthetic medicine API manufacturing<\/td><\/tr><tr><td><strong>Primary Products<\/strong><\/td><td>Orforglipron (oral GLP\u20111 RA), small molecules, peptides<\/td><\/tr><tr><td><strong>Permanent Jobs<\/strong><\/td><td>450 high\u2011value roles (engineers, scientists, operations, lab technicians)<\/td><\/tr><tr><td><strong>Construction Jobs<\/strong><\/td><td>3,000 (peak during 2026\u20112032 build)<\/td><\/tr><tr><td><strong>Construction Start<\/strong><\/td><td>2026<\/td><\/tr><tr><td><strong>Completion<\/strong><\/td><td>2032<\/td><\/tr><tr><td><strong>Strategic Context<\/strong><\/td><td>Third of four new US sites planned by Lilly<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-significance\">Strategic Significance<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Orforglipron Positioning:<\/strong> Lilly expects to submit orforglipron to global regulatory agencies for <strong>obesity<\/strong> by <strong>end\u20112025<\/strong>, positioning it as a key oral alternative to injectable GLP\u20111 therapies.<\/li>\n\n\n\n<li><strong>Capacity Ramp:<\/strong> The Alabama site will be among the primary manufacturing locations for orforglipron, addressing <strong>surging global demand<\/strong> for GLP\u20111 medications that currently faces supply constraints.<\/li>\n\n\n\n<li><strong>US Manufacturing Footprint:<\/strong> The investment reinforces Lilly\u2019s commitment to domestic production amid US policy incentives for onshoring critical drug manufacturing.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity\">Market Opportunity<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Value<\/th><th>Implication<\/th><\/tr><\/thead><tbody><tr><td><strong>Global GLP\u20111 Market<\/strong><\/td><td>$35\u202fbillion (2025)<\/td><td>Projected to exceed $60\u202fbillion by 2030<\/td><\/tr><tr><td><strong>Oral GLP\u20111 Share<\/strong><\/td><td>&lt;$1\u202fbillion today<\/td><td>Oral agents could capture 30\u201140% of market<\/td><\/tr><tr><td><strong>Obesity Patients (US)<\/strong><\/td><td>42% of adult population<\/td><td>&lt;5% currently receive pharmacotherapy<\/td><\/tr><tr><td><strong>Orforglipron Peak Sales<\/strong><\/td><td><strong>$8\u201112\u202fbillion<\/strong> (global estimate)<\/td><td>If approved, would compete with Novo\u2019s Rybelsus and injectables<\/td><\/tr><tr><td><strong>Manufacturing Scale<\/strong><\/td><td>Huntsville facility to support <strong>&gt;10\u202fmillion patient\u2011years<\/strong> annually<\/td><td>Critical to meet projected demand<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding Lilly\u2019s investment timeline, orforglipron regulatory submissions, and market projections. Actual results may differ due to regulatory delays, competitive responses, or construction setbacks.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly &amp; Co. (NYSE: LLY) announced plans to invest more than USD\u202f6\u202fbillion in a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":50617,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[199,911],"class_list":["post-50616","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-eli-lilly","tag-nyse-lly"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Eli Lilly &amp; Co. (NYSE: LLY) announced plans to invest more than USD\u202f6\u202fbillion in a new manufacturing facility in Huntsville, Alabama. The next\u2011generation active pharmaceutical ingredient (API) plant will produce small molecule synthetic and peptide medicines, including orforglipron, Lilly\u2019s first oral small\u2011molecule GLP\u20111 receptor agonist targeted for obesity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=50616\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron\" \/>\n<meta property=\"og:description\" content=\"Eli Lilly &amp; Co. (NYSE: LLY) announced plans to invest more than USD\u202f6\u202fbillion in a new manufacturing facility in Huntsville, Alabama. The next\u2011generation active pharmaceutical ingredient (API) plant will produce small molecule synthetic and peptide medicines, including orforglipron, Lilly\u2019s first oral small\u2011molecule GLP\u20111 receptor agonist targeted for obesity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=50616\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-13T14:22:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-13T14:22:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1303.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron\",\"datePublished\":\"2025-12-13T14:22:42+00:00\",\"dateModified\":\"2025-12-13T14:22:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616\"},\"wordCount\":304,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1303.webp\",\"keywords\":[\"Eli Lilly\",\"NYSE: LLY\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=50616#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=50616\",\"name\":\"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1303.webp\",\"datePublished\":\"2025-12-13T14:22:42+00:00\",\"dateModified\":\"2025-12-13T14:22:43+00:00\",\"description\":\"Eli Lilly & Co. (NYSE: LLY) announced plans to invest more than USD\u202f6\u202fbillion in a new manufacturing facility in Huntsville, Alabama. The next\u2011generation active pharmaceutical ingredient (API) plant will produce small molecule synthetic and peptide medicines, including orforglipron, Lilly\u2019s first oral small\u2011molecule GLP\u20111 receptor agonist targeted for obesity.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=50616\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1303.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1303.webp\",\"width\":1080,\"height\":608,\"caption\":\"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50616#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron - Insight, China&#039;s Pharmaceutical Industry","description":"Eli Lilly & Co. (NYSE: LLY) announced plans to invest more than USD\u202f6\u202fbillion in a new manufacturing facility in Huntsville, Alabama. The next\u2011generation active pharmaceutical ingredient (API) plant will produce small molecule synthetic and peptide medicines, including orforglipron, Lilly\u2019s first oral small\u2011molecule GLP\u20111 receptor agonist targeted for obesity.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=50616","og_locale":"en_US","og_type":"article","og_title":"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron","og_description":"Eli Lilly & Co. (NYSE: LLY) announced plans to invest more than USD\u202f6\u202fbillion in a new manufacturing facility in Huntsville, Alabama. The next\u2011generation active pharmaceutical ingredient (API) plant will produce small molecule synthetic and peptide medicines, including orforglipron, Lilly\u2019s first oral small\u2011molecule GLP\u20111 receptor agonist targeted for obesity.","og_url":"https:\/\/flcube.com\/?p=50616","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-13T14:22:42+00:00","article_modified_time":"2025-12-13T14:22:43+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1303.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=50616#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=50616"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron","datePublished":"2025-12-13T14:22:42+00:00","dateModified":"2025-12-13T14:22:43+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=50616"},"wordCount":304,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=50616#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1303.webp","keywords":["Eli Lilly","NYSE: LLY"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=50616#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=50616","url":"https:\/\/flcube.com\/?p=50616","name":"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=50616#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=50616#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1303.webp","datePublished":"2025-12-13T14:22:42+00:00","dateModified":"2025-12-13T14:22:43+00:00","description":"Eli Lilly & Co. (NYSE: LLY) announced plans to invest more than USD\u202f6\u202fbillion in a new manufacturing facility in Huntsville, Alabama. The next\u2011generation active pharmaceutical ingredient (API) plant will produce small molecule synthetic and peptide medicines, including orforglipron, Lilly\u2019s first oral small\u2011molecule GLP\u20111 receptor agonist targeted for obesity.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=50616#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=50616"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=50616#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1303.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1303.webp","width":1080,"height":608,"caption":"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=50616#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Lilly to Invest Over $6\u202fBillion in Alabama GLP\u20111 Manufacturing Hub for Orforglipron"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1303.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/50616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50616"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/50616\/revisions"}],"predecessor-version":[{"id":50618,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/50616\/revisions\/50618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/50617"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}